Purpose: Patients with multiple endocrine neoplasia type 1 (MEN1) are predisposed to develop duodenopancreatic neuroendocrine tumors (dpNETs), and metastatic dpNET is the primary cause of disease-rela
People living with cancer have a profound need to understand any potential negative impacts of treatment on their everyday lives and whether the treatment itself could cause other long-term health cha